Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

With proper management, diabetes does not need to take your life. If you recognise any of the symptoms, consult your doctor ...

Today (14 November) is World Diabetes Day. We asked our commentators how HR can support employees with diabetes.

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Diabetes affects 25 pc of Kerala's population, with lifestyle choices playing a major role. Learn about prediabetes symptoms, ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...